Neuroimmunology News

Feb 22, 2017
tDCS combined with computer games at home reduces cognitive symptoms of multiple sclerosis
Patients with multiple sclerosis had better problem solving ability and response time after training with transcranial direct current stimulation (tDCS), according to a new study published February 22, 2017 in Neuromodulation: Technology at the Neural Interface.
Jan 23, 2017
Serum micoRNAs may serve as biomarkers for multiple sclerosis
In a new study published today in JAMA Neurology, researchers have found that serum microRNAs are linked to MRI findings in the brain and spinal cord in patients with multiple sclerosis (MS). These findings suggest that microRNAs could serve as promising biomarkers for monitoring the progression of MS.
Jan 18, 2017
Researchers discover severe side effects of approved multiple sclerosis medication
The multiple sclerosis therapy alemtuzumab can trigger severe, unpredictable side effects, finds by a team led by German researchers published in the journal Lancet Neurology. The team also describes a treatment that successfully curbed the harmful side effects.
Jan 06, 2017
New treatment for a rare form of encephalitis
German researchers have shown for the first time that bortezomib treatment quickly resulted in clinical improvements in patients with severe forms of anti-NMDA receptor encephalitis. Treatment was also associated with a decline in the antibodies responsible for the disease.
Nov 18, 2016
Study links mothers with rheumatoid arthritis and kids with epilepsy
A new study published in the current issue of Neurology shows a link between mothers with rheumatoid arthritis and children with epilepsy. Having a father with rheumatoid arthritis did not have any effect on whether the child would develop epilepsy.
Sep 21, 2016
Drug may prevent, reduce progression of multiple sclerosis in mice
The experimental drug laquinimod may prevent the development or reduce the progression of multiple sclerosis in mice, according to research published in the September 21, 2016, online issue of Neurology® Neuroimmunology & Neuroinflammation.
Jul 13, 2016
Changes uncovered in the gut bacteria of patients with multiple sclerosis
Study finds alterations in the gut microbiomes of treated and untreated multiple sclerosis patients
Jul 07, 2016
Brain inflammation linked to depression in multiple sclerosis
A new study in Biological Psychiatry reports that hippocampal inflammation could be the contributing cause of high rates of depression in multiple sclerosis. The authors predict that an effective and targeted treatment of brain inflammation would help to restore brain function and protect against depression in multiple sclerosis.
Jun 27, 2016
Teaching an old drug new tricks to fight cytomegalovirus
Researchers at Johns Hopkins have found that an old drug once mostly used to treat amebiasis and induce vomiting in cases of poisoning appears to also halt replication of cytomegalovirus (CMV). A report on the finding, made in test tube and mice studies, is published in the June 23 PLOS Pathogens and could potentially offer a much-needed tool to inhibit CMV.
Jun 20, 2016
Four new risk genes associated with multiple sclerosis discovered
Scientists of the Technical University of Munich and the Max Planck Institute of Psychiatry have identified 4 new risk genes that are altered in patients with multiple sclerosis. The results point to a possible involvement of cellular mechanisms in the development of the disease, through which environmental influences affect gene regulation.
Next ▶